We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Cas Medical Systems, Inc. | NASDAQ:CASM | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 2.45 | 2.44 | 2.45 | 0 | 01:00:00 |
"We are pleased to welcome Kim to CASMED to lead our efforts in accelerating the commercial success of FORE-SIGHT cerebral oximeters and sensors in the U.S.," said Thomas M. Patton, President and Chief Executive Officer of CASMED. "Kim is an experienced sales professional and has built and managed sales organizations and clinical sales teams that captured market leadership positions. Most relevant, Kim propelled depth-of-anesthesia monitor and disposables sales at Aspect Medical from $10 million to $70 million annually before the company was acquired by Covidien. Her extensive experience in conceptual and clinical selling, sales management, strategic planning and sales training makes Kim an important addition to the CASMED team as we continue to build on the strong U.S. performance of our FORE-SIGHT business, which has reported 21 consecutive quarters of double-digit sensor sales growth."
Most recently, Ms. Strusky was Vice President of Sales at CSA Medical, a start-up medical device company where she created and led a sales organization selling cryoablation technologies. Earlier in her career, she spent eight years with Baxter Healthcare and eight years with STERIS Corporation in the field sales organizations. Ms. Strusky received her Bachelor of Science in Management degree from Purdue University.
About CASMED® – Monitoring What's Vital
CASMED is a leading developer and manufacturer of medical devices for non-invasive patient monitoring. The Company's FORE-SIGHT Absolute Cerebral Oximeter provides a highly accurate, non-invasive, continuous measurement of absolute cerebral tissue oxygen saturation. Direct monitoring of tissue oxygenation provides a superior and powerful tool to alert clinicians to otherwise unrecognized and dangerously low levels of oxygenation of the brain and other tissues, thereby allowing them to intervene appropriately in the care of their patients. In addition to FORE-SIGHT Oximeters and accessories, the Company provides a line of bedside patient vital signs monitoring products, proprietary non-invasive blood pressure monitoring solutions for OEM use, neonatal intensive care supplies, and service. CASMED products are designed to provide unique monitoring solutions that are vital to patient care. For further information regarding CASMED, visit the Company's website at www.casmed.com.
Company Contact CAS Medical Systems, Inc. Jeffery A. Baird Chief Financial Officer (203) 315-6303 ir@casmed.com
Investors LHA Bruce Voss / Jody Cain (310) 691-7100 bvoss@lhai.com / jcain@lhai.com @LHA_IR_PR
1 Year Cas Medical Systems, Inc. Chart |
1 Month Cas Medical Systems, Inc. Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions